{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n HNRNPCL proteins have emerged as multifunctional RNA‐binding regulators that appear to contribute to tumor progression through diverse mechanisms. In colorectal cancer, for example, a family member known as RALY (hnRNPCL2) functions as a key component of the Drosha complex to facilitate the processing of specific microRNAs that ultimately reprogramme mitochondrial metabolism and promote tumor aggressiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, high‐frequency mutations affecting another family member, HNRNPCL1, have been identified in endometrial cancer, suggesting that genetic alterations within the hnRNPCL family may be relevant to tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In an independent study exploring biomarkers in medulloblastoma, a set of heterogeneous nuclear ribonucleoproteins—including HNRNPCL4—was uniquely detected in the extracellular microvesicles shed by aggressive, stem‐like tumor cells that exhibit activation of oncogenic signaling cascades such as ERK, PI3K/AKT/mTOR, EGF/EGFR, and stem cell self‐renewal."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Although a separate abstract focused on caerin peptides does not directly address the functional roles of HNRNPCL proteins"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", the collective evidence indicates that HNRNPCL4—in the context of medulloblastoma—may be involved in facilitating intercellular communication and modulating oncogenic pathways. Its specific enrichment within tumor‐derived microvesicles underscores its potential utility as a biomarker for aggressive disease and early detection of relapse, while also highlighting that mechanistic insights gleaned from other hnRNPCL family members may inform future studies on HNRNPCL4.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Lei Sun, Arabella Wan, Zhuolong Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gut (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/gutjnl-2020-320652"}], "href": "https://doi.org/10.1136/gutjnl-2020-320652"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33219048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33219048"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yuan Gao, Xiuping Zhang, Tian Wang, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "HNRNPCL1, PRAMEF1, CFAP74"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": ", and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "DFFB"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": ": Common Potential Biomarkers for Sporadic and Suspected Lynch Syndrome Endometrial Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S262421"}], "href": "https://doi.org/10.2147/CMAR.S262421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33177874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33177874"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Carolini Kaid, Amanda Assoni, Marina Marçola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2020.146646"}], "href": "https://doi.org/10.1016/j.brainres.2020.146646"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31917138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31917138"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Guoying Ni, Di Liang, Scott F Cummins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2018/7382351"}], "href": "https://doi.org/10.1155/2018/7382351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29862288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29862288"}]}]}]}